Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFuture Metals Regulatory News (FME)

  • There is currently no data for FME

Performance Rights Conversion

23 Nov 2023 08:15

RNS Number : 4607U
Future Metals NL
23 November 2023
 

23 November 2023

Future Metals NL

Performance Rights Conversion, Issue of Securities, Director Dealing and Change of Admission Date for Osprey Consideration Shares

Future Metals NL ("Future Metals" or the "Company", ASX|AIM: FME) announces, in accordance with the terms of the Company's Performance Rights Plan and the previous issue of Performance Rights approved by shareholders at the Company's general meeting held on 4 June 2021, that 1,966,666 Performance Rights have been converted at nil cost into 1,966,666 fully paid new ordinary shares of no par value each in the Company ("Ordinary Shares") by a Director and certain technical contractors of the Company (the "Conversion Shares") (the "Conversion").

800,000 Conversion Shares shall be issued to Mr Jardee Kininmonth, Managing Director & CEO of the Company. Following the Conversion, Mr Kininmonth will be interested in 1,588,605 Ordinary Shares, representing approximately 0.36% of the Company's issued share capital and further information of Mr other options and remaining Performance Rights held in the Company is set out the Appendix 3Y, available at the following link:

http://www.rns-pdf.londonstockexchange.com/rns/4607U_1-2023-11-23.pdf

Change of Admission Date for Osprey Consideration Shares

Future Metals also announces that, further to the Company's announcement on 17 November 2023, the admission of the 18,382,352 Consideration Shares (as defined in such announcement) to trading on AIM is now expected to occur at 8.00 a.m. on or around 24 November 2023.

Admission to Trading on AIM and Total Voting Rights

Application has been made to the London Stock Exchange plc for the admission to trading on AIM of the abovementioned 18,382,352 Consideration Shares on 24 November 2023 and for the admission of the 1,966,666 Conversion Shares on 28 November 2023 ("Admission"). Admission is expected to take effect and dealings commence at 8.00 a.m. (London time) on or around 24 and 28 November 2023, respectively.

Following admission of the Consideration Shares, the number of Ordinary Shares in issue, and the total voting rights in the Company will be 440,253,055. Following admission of the Conversion Shares, the number of Ordinary Shares in issue, and the total voting rights in the Company will be 442,219,721. These figures may be used by shareholders as the denominator for the calculations by which they determine whether they are required to notify their interest in, or a change of their interest in, the Company under the provisions of the Company's constitution. 

This announcement has been approved for release by the Board of Future Metals NL.

Further Information

 

For further information please refer to the ASX platform under ASX code FME or visit the Company's website at www.future-metals.com.au.

 

Future Metals NL

+61 8 9480 0414

Jardee Kininmonth

info@future-metals.com.au

Strand Hanson Limited (Nominated Adviser)

+44 (0) 207 409 3494

James Harris/James Bellman

Panmure Gordon (UK) Limited (UK Broker)

John Prior/Hugh Rich/Rauf Munir

+44 (0)207 886 2500

FlowComms (UK IR/PR)

+44 (0) 789 167 7441

Sasha Sethi

 

PDMR Notification Form:

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jardee Kininmonth

2.

Reason for the Notification

a)

Position/status

Managing Director & CEO

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Future Metals NL

b)

LEI

213800WZ1MNQPOAKNU50

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares

Identification code

AU0000157745

b)

Nature of the Transaction

Conversion of performance rights into new Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

800,000

d)

Aggregated information

Aggregated volume Price

N/A (Single transaction)

e)

Date of the transaction

21 November 2023

f)

Place of the transaction

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCVXLBLXFLFFBL
Date   Source Headline
17th Nov 20227:00 amRNSSulphide Intercepts Define New Target Zone
16th Nov 20229:00 amRNSIssue of Performance Rights
16th Nov 20227:00 amRNSAppointment of Corporate Broker
10th Nov 20228:45 amRNSIssue of Options
8th Nov 20227:00 amRNSResults of 2022 Annual General Meeting
7th Nov 20227:00 amRNSDirector's Dealing
3rd Nov 20227:00 amRNSDrilling Confirms Sulphide System at Panton
28th Oct 20227:00 amRNSQuarterly Activities Report to 30 September 2022
11th Oct 20227:00 amRNSDrilling to Commence at Panton
6th Oct 20227:05 amRNSExercise of Options
6th Oct 20227:00 amRNSAvailability of Notice of Annual General Meeting
3rd Oct 20227:00 amRNSFinal Results for the Year Ended 30 June 2022
3rd Oct 20227:00 amRNSUK Placement
16th Sep 20227:00 amRNSDirector’s Dealing
15th Sep 20227:00 amRNSOperational Update
14th Sep 20222:34 pmRNSUpdate re Share Purchase Plan Allotments
14th Sep 20229:00 amRNS2022 AGM and Director Nominations
12th Sep 20229:39 amRNSResults of Share Purchase Plan
25th Aug 20221:30 pmRNSCleansing Notice and Appendix 2A
22nd Aug 20227:00 amRNSPublication of Prospectus re SPP Offer
17th Aug 20227:00 amRNSPlacement and Share Purchase Plan
15th Aug 20227:00 amRNSASX Trading Halt
4th Aug 20227:00 amRNSPerformance Rights, Issue of Securities and TVR
1st Aug 202210:15 amRNSHolding(s) in Company
1st Aug 20227:00 amRNSDirectorate Change
29th Jul 20227:00 amRNSQuarterly Activities and Cash Flow to 30 June 2022
27th Jul 20227:00 amRNSHigh grade Ni-Cu-PGE sulphides confirmed at Panton
28th Jun 20228:17 amRNSDirector Dealing
21st Jun 20227:00 amRNSJORC Mineral Resource Estimate
16th Jun 20227:00 amRNSOptions to Commence Trading on ASX
7th Jun 202210:07 amRNSOptions Placement and Quotation
12th May 20227:00 amRNSAssay Results and Commencement of MRE
11th May 20228:20 amRNSDirectorate Change
29th Apr 20227:01 amRNSAppendix 5B
29th Apr 20227:01 amRNSAppendix 5B
29th Apr 20227:00 amRNSQuarterly Activities and Cashflow Report
22nd Apr 20228:55 amRNSHistorical Drilling Assays
4th Apr 20227:00 amRNSOperational Update & Management Appointment
8th Mar 202212:00 pmRNSHalf Year Report
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20221:17 pmRNSPanton Drilling Results
17th Feb 20227:12 amRNSDrilling Continues at the Panton PGM-Ni Deposit
8th Feb 202211:35 amRNSPerformance Rights Conversion and TVR
31st Jan 20227:46 amRNSAppendix 5B
31st Jan 20227:45 amRNSQuarterly Report for the period ended 31 Dec 2021
31st Jan 20227:00 amRNSBoard Changes and Senior Management Appointments
17th Jan 20228:45 amRNSFurther Assay Results from the Panton Deposit
17th Jan 20227:00 amRNSExpiry of Unlisted Options
8th Dec 20217:00 amRNSBulk Tonnage from Surface at Panton PGM-Ni Deposit

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.